| Oct 15 |
AMGEN PRESENTS POSITIVE PHASE 3 DATA FOR UPLIZNA® (INEBILIZUMAB-CDON) IN GENERALIZED MYASTHENIA GRAVIS (GMG) AT AANEM 2024
|
| Oct 14 |
Why Amgen's Obesity Drug — And $5 Billion Opportunity — Led To A Downgrade
|
| Oct 14 |
Amgen Seeing Muted Upside Potential for Drug Pipeline, Truist Says
|
| Oct 14 |
Amgen Stock Falls. The Obesity Drug Landscape Is Getting Crowded.
|
| Oct 14 |
Amgen Inc. (NASDAQ:AMGN) Delivered A Better ROE Than Its Industry
|
| Oct 14 |
Amgen downgraded at Truist on MariTide prospects for obesity
|
| Oct 11 |
2 Top Dividend Stocks to Buy Hand Over Fist Right Now
|
| Oct 10 |
Deere, Amgen, Copart And More: CNBC's 'Final Trades'
|
| Oct 9 |
2 Biotech Stocks to Buy Hand Over Fist in October
|
| Oct 8 |
Amgen and MediLink to collaborate on SCLC combination therapy
|
